It is a trading private limited company based in Karchhana, Uttar Pradesh, India, established in 2020.
2020 | Karchhana, Uttar Pradesh, India | ActiveSpyka Pharmaceuticals Private Limited, a active private limited company, was established on 18 February 2020 in Karchhana, Uttar Pradesh, India. Engaging in specialty within the trading sector, it holds CIN: U51909UP2020PTC127158. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Nidhi Mishra (Additional Director), Uma Shukla (Additional Director). Past directors included Nidhi Mishra, Praveen Gupta, Prabhakar Singh. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Arazi 48 Chak Imam Ali, Manas Nagar, Naini, Karchhana, Uttar Pradesh, 211008.
U51909UP2020PTC127158
127158
18 February 2020
₹1.00 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Spyka Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nidhi Mishra | Additional Director | 24 Nov 2023 | Current |
| Uma Shukla | Additional Director | 24 Nov 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 21 May 2024 | Past |
| Pramod Abcsdd | Director | 14 Feb 2024 | Past |
| Pramod Abcsdd | Director | 14 Feb 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spyka Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 1.95% decrease in profit. The company's net worth dipped by a decrease of 2.53%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Spyka Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Spyka Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Spyka Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spyka Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Spyka Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Spyka Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.
The activity Nidhi Mishra was appointed as a Additional Director was appointed as a Additional Director on 24 Nov 2023 & has been associated with this company since 2 years 25 days . was completed.
Uma Shukla was appointed as a Additional Director was appointed as a Additional Director on 24 Nov 2023 & has been associated with this company since 2 years 25 days . was recorded as a recent event.
Progress on Spyka Pharmaceuticals Private Limited was registered on 18 Feb 2020 with Roc Kanpur & aged 5 years 10 months as per MCA records. was documented.
The CIN of Spyka Pharmaceuticals Private Limited is U51909UP2020PTC127158.
Spyka Pharmaceuticals Private Limited is headquartered at Arazi 48 Chak Imam Ali, Manas Nagar, Naini, Karchhana, Uttar Pradesh, 211008.
Spyka Pharmaceuticals Private Limited was incorporated on 18 February 2020.
The current directors of Spyka Pharmaceuticals Private Limited are
The primary industry of Spyka Pharmaceuticals Private Limited is Trading.
Spyka Pharmaceuticals Private Limited is unlisted.
The authorized capital of Spyka Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX